, Tracking Stock Market Picks
Enter Symbol:
Discovery Laboratories, Inc. (DSCO) [hlAlert]

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the
ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.
( Total: 7 Current Stock Recommendations )
Discovery Laboratories, Inc.   (7)
Sell 29% Buy 71%
Related companies

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy